Innovations in Diabetes Care for a Better "New Normal" Beyond COVID-19

J Clin Endocrinol Metab. 2021 Jan 1;106(1):e377-e381. doi: 10.1210/clinem/dgaa704.

Abstract

The coronavirus disease pandemic has created opportunities for innovation in diabetes care that were not possible before. From the lens of this "new normal" state, we have an opportunity to rapidly implement, test, and iterate models of diabetes care to achieve the quadruple aim of improving medical outcomes, patient experience, provider satisfaction, and reducing costs. In this perspective, we discuss several innovative diabetes models of care which promote collaborative care models and improve access to high-quality specialty diabetes care. We discuss ongoing threats to diabetes care innovation, and offer practical solutions to foster evolution and sustain current strides made during the pandemic.

Keywords: COVID-19; alternative models of care; diabetes care; healthcare delivery; innovation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19 / epidemiology*
  • Diabetes Mellitus / therapy*
  • Humans
  • Patient Care Team
  • Pharmacists
  • Referral and Consultation
  • SARS-CoV-2*
  • Telemedicine